Our findings open the possibility of designing randomized studies to assess if the optimization of preoperative Hb concentration, through the use of erythropoietin and/or iron therapy, would reduce perioperative transfusion and the incidence of ventricular arrhythmia, acute renal failure, and postoperative low cardiac output. This evidence concerns the gene EPO and Ventricular arrhythmia.